Prof Abeer Shaaban

Prof Abeer Shaaban is a Consultant Pathologist at Queen Elizabeth Hospital Birmingham and Professor of Cancer and Genomic Sciences, University of Birmingham, UK. She is Professional Clinical Advisor (PCA) for the UK NHS Breast Screening Programme and Pathology lead for the NHS Genomic Medicine Service Alliance (GMSA) for Central and South.

She published over 200 peer reviewed publications and contributed to a number of guidelines guidelines including in the WHO Blue Book for  Genomic Syndromes 2023, the WHO Blue Book for Breast tumours 2019,  the International Collaboration on Cancer Reporting (ICCR)  DCIS dataset 2021, the RCPath Breast Pathology reporting guidelines (2023) and the European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.

She co-edited a textbook of molecular pathology entitled “Molecular pathology for the practising surgical pathologist and cytopathologists”, led a large number of research studies and contributed to a number of  breast cancer trials.